As Corbin et al. demonstrated that LSCs escape from IM treatment independently from BCR-ABL kinase activity, we sought to identify those miRNAs that were deregulated in CML LSCs with a mechanism that is independent from BCR-ABL. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.